Akio Yamasaki Selected Research

Akio Yamasaki Research Topics

Disease

16	Neoplasms (Cancer) 05/2022 - 07/2008
8	Pancreatic Neoplasms (Pancreatic Cancer) 08/2021 - 03/2009
6	Hypoxia (Hypoxemia) 05/2022 - 02/2016
3	Inflammation (Inflammations) 05/2022 - 12/2009
2	Adenocarcinoma 08/2021 - 01/2020
2	Gallbladder Neoplasms (Gallbladder Cancer) 01/2018 - 05/2017
2	Breast Neoplasms (Breast Cancer) 01/2017 - 03/2009
2	Stomach Neoplasms (Stomach Cancer) 07/2011 - 03/2009
2	Colonic Neoplasms (Colon Cancer) 12/2009 - 03/2009
2	Carcinoma (Carcinomatosis) 03/2009 - 07/2008
1	Ascites 02/2016
1	Cysts 01/2016
1	Colorectal Neoplasms (Colorectal Cancer) 07/2011
1	Pleural Effusion (Pleural Effusions) 03/2009

Drug/Important Bio-Agent (IBA)

4	Proteins (Proteins, Gene)FDA Link 03/2019 - 03/2009
3	TropomyosinIBA 08/2021 - 01/2017
3	Brain-Derived Neurotrophic Factor (BDNF)IBA 08/2021 - 05/2017
3	Phosphotransferases (Kinase)IBA 08/2021 - 01/2017
3	Small Interfering RNA (siRNA)IBA 03/2019 - 07/2011
3	Carrier Proteins (Binding Protein)IBA 08/2018 - 02/2016
3	Immunoglobulins (Immunoglobulin)IBA 08/2018 - 02/2016
3	NF-kappa B (NF-kB)IBA 05/2010 - 03/2009
2	CytokinesIBA 05/2022 - 03/2009
2	Leukocyte Common Antigens (CD45 Antigen)IBA 03/2019 - 12/2017
2	Vascular Endothelial Growth Factor A (Vascular Endothelial Growth Factor)IBA 05/2017 - 03/2009
2	Transforming Growth Factor beta (TGF-beta)IBA 05/2010 - 03/2009
1	Reactive Oxygen Species (Oxygen Radicals)IBA 05/2022
1	Receptor Protein-Tyrosine Kinases (Tyrosine Kinase Receptors)IBA 01/2018
1	ONO-7579IBA 01/2018
1	Vascular Endothelial Growth Factor CIBA 05/2017
1	Vascular Endothelial Growth Factor DIBA 05/2017
1	Fluorouracil (Carac)FDA LinkGeneric 01/2017
1	Cisplatin (Platino)FDA LinkGeneric 01/2017
1	Neutralizing AntibodiesIBA 12/2016
1	Matrix Metalloproteinases (MMPs)IBA 08/2016
1	polysaccharide-KIBA 08/2016
1	DNA (Deoxyribonucleic Acid)IBA 02/2016
1	Matrix Metalloproteinase 2 (Gelatinase A)IBA 02/2016
1	Alkaline PhosphataseIBA 02/2016
1	Gemcitabine FDA Link 02/2016
1	Octamer Transcription Factor-3 (Oct 4 Transcription Factor)IBA 02/2016
1	Conditioned Culture MediaIBA 02/2016
1	Epithelial Cell Adhesion MoleculeIBA 02/2016
1	Leukemia Inhibitory FactorIBA 02/2016
1	Mitogen-Activated Protein KinasesIBA 07/2011
1	2- (4- morpholinyl)- 8- phenyl- 4H- 1- benzopyran- 4- oneIBA 07/2011
1	2- (2- amino- 3- methoxyphenyl)- 4H- 1- benzopyran- 4- oneIBA 07/2011
1	Phosphatidylinositols (Phosphatidylinositol)IBA 07/2011
1	Paclitaxel (Taxol)FDA LinkGeneric 07/2011
1	Sirolimus (Rapamycin)FDA Link 07/2011
1	InterferonsIBA 07/2011
1	Interleukin-2 (IL2)IBA 07/2011
1	Peptides (Polypeptides)IBA 07/2011
1	Zoledronic Acid (Zometa)FDA Link 07/2011
1	HLA-A24 AntigenIBA 07/2011
1	matrigelIBA 12/2009
1	LipopolysaccharidesIBA 12/2009
1	Interleukin-10 (Interleukin 10)IBA 03/2009
1	Polysaccharides (Glycans)IBA 03/2009
1	LigandsIBA 03/2009
1	cyclopamineIBA 03/2009
1	Docetaxel (Taxotere)FDA Link 03/2009
1	Bevacizumab (Avastin)FDA Link 03/2009
1	Estrogen ReceptorsIBA 03/2009
1	Estrogen Receptor alphaIBA 03/2009
1	VaccinesIBA 07/2008

Therapy/Procedure

5	Therapeutics 05/2022 - 07/2008
5	Immunotherapy 01/2020 - 07/2008
2	Drug Therapy (Chemotherapy) 01/2020 - 07/2011
1	Gastrectomy 01/2016
1	Lymph Node Excision (Lymph Node Dissection) 01/2016
1	Intravenous Injections 07/2008
1	Subcutaneous Injections 07/2008